BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1458456)

  • 1. Concomitant presence of trisomy 21 and del(9q) in acute myeloid leukemia.
    Kwong YL; Chan LC
    Cancer Genet Cytogenet; 1992 Nov; 64(1):92-4. PubMed ID: 1458456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
    Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
    Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial 9q- deletion in a case of acute myeloid leukemia-M2 arising from a granulocytic sarcoma.
    Lunde JH; Allen EF
    Cancer Genet Cytogenet; 1994 Dec; 78(2):239-41. PubMed ID: 7828160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
    Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
    Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of M2 acute myeloblastic leukemia associated with an interstitial 9q deletion.
    Lin CC; De Braekeleer M; Etches WS; Thay TY
    Cancer Genet Cytogenet; 1987 Jan; 24(1):177-80. PubMed ID: 3466670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial deletion of 9q revisited.
    Kwong YL; Ha SY; Ching LM; Chan LC
    Leuk Lymphoma; 1993 Dec; 12(1-2):153-5. PubMed ID: 8161932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.
    Naarmann-de Vries IS; Sackmann Y; Klein F; Ostareck-Lederer A; Ostareck DH; Jost E; Ehninger G; Brümmendorf TH; Marx G; Röllig C; Thiede C; Crysandt M
    Leuk Res; 2019 Jan; 76():15-23. PubMed ID: 30476680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion 9q as the sole karyotypic abnormality in myelocytic disorders: a new case of myelodysplastic syndrome and its prognostic implications in acute myelocytic leukemia.
    Wan TS; Ma ES; Lam CC; Chan LC; Lee KK; Au WY
    Cancer Genet Cytogenet; 2003 Sep; 145(2):184-6. PubMed ID: 12935935
    [No Abstract]   [Full Text] [Related]  

  • 10. Trisomy 4 in acute myeloblastic and acute lymphoblastic leukemia.
    Zollino M; Leone G; Sica S; Bajer J; Neri G
    Cancer Genet Cytogenet; 1993 Feb; 65(2):115-9. PubMed ID: 8453596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial 9q deletion in T-lymphoid/myeloid biphenotypic leukaemia.
    Akashi K; Shibuya T; Harada M; Oogami A; Teshima T; Takamatsu Y; Kikuchi M; Niho Y
    Br J Haematol; 1992 Feb; 80(2):172-7. PubMed ID: 1550772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.
    Ferrara F; Scognamiglio M; Di Noto R; Schiavone EM; Poggi V; Fiorillo A; Libertini R; Vicari L; Del Vecchio L; Sebastio L
    Leukemia; 1996 Dec; 10(12):1990-2. PubMed ID: 8946942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. del(2)(p23) as a sole abnormality in a case of acute myeloid leukemia.
    Sundareshan TS; Madhumathi DS; Appaji L
    Cancer Genet Cytogenet; 2002 Apr; 134(2):172-4. PubMed ID: 12034535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
    Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
    Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Del (9q) AML: clinical and cytological characteristics and prognostic implications.
    Peniket A; Wainscoat J; Side L; Daly S; Kusec R; Buck G; Wheatley K; Walker H; Chatters S; Harrison C; Boultwood J; Goldstone A; Burnett A
    Br J Haematol; 2005 Apr; 129(2):210-20. PubMed ID: 15813849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. del(2)(p23): a new recurrent abnormality in acute myeloid leukemia.
    Najfeld V; Scalise A; Fruchtman S; Troy K
    Cancer Genet Cytogenet; 1990 Jun; 46(2):185-90. PubMed ID: 2340489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6p+ and 9q- in two chromosomally distinct clones occurring in a case of myelodysplastic syndrome evolving to acute nonlymphocytic leukemia.
    Ringressi A; Mecucci C; Grossi A; Bernabei PA; Ferrini PR; Van den Berghe H
    Cancer Genet Cytogenet; 1988 Oct; 35(2):213-21. PubMed ID: 3052797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. del(2)(p23): a consistent recurrent abnormality in acute myelogenous leukemia.
    Verma RS; Macera MJ; da Costa M; Bradley T; Christodoulidou F
    Cancer Genet Cytogenet; 1991 Dec; 57(2):175-9. PubMed ID: 1756495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
    Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
    Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.